In addition to alleviating immunosuppression mediated by MDSC, further increases in CD8+/Treg ratio by adding anti-CCR2 to combined IR + cGAMP treatment, alleviating suppression of a different type, may be responsible for the superior anti-tumor immunity we observed. This evidence concerns the gene CCR2 and neoplasm.